Sign In
About ASHM | Careers | Your Cart Shoppint Cart
Skip Navigation LinksASHM Internet Home > Boceprevir and telaprevir to be listed on the Pharmaceutical Benefits Scheme. ASHM welcomes subsidies for new hepatitis treatment drugs

Boceprevir and telaprevir to be listed on the Pharmaceutical Benefits Scheme. ASHM welcomes subsidies for new hepatitis treatment drugs

Media Release |
Hepatitis C |
  |
National |
  |
ASHM |
Other |
  |
ASHM welcomes today's announcement that two new hepatitis C treatment drugs – boceprevir and telaprevir – will be listed on the Pharmaceutical Benefits Scheme.

19 February 2013

The Australasian Society for HIV Medicine (ASHM) welcomes today's announcement that two new hepatitis C treatment drugs – boceprevir and telaprevir – will be listed on the Pharmaceutical Benefits Scheme (PBS). ​

Read the media release.

Please enter a valid E-mail.
This must match your colleagues E-mail.
Please enter your name.
Please enter a valid email.
This must match your email.